We represented Bayer in this application under the PMNOC Regulations. The validity of Bayer’s patent covering the oral contraceptives YASMIN® and YAZ® was upheld by the Federal Court. While Apotex’s non-infringement allegations were found to be justified in this case, Apotex’s generic products were found to infringe the patent at issue in a subsequent infringement action (2016 FC 1013).